RxDoctor Payments Data

Bayard Carlson, MD

Orthopaedic Surgery · Minneapolis, MNNPI 1881084853

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Medtronic at 46.2% of the total. Reporting peaked in 2024 at $23,060 and has fallen 62.2% since, to $8,719 in 2025.

$59,991in general payments, 2019–2025

Across 194 payments — averaging $309.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$28K
  • Stryker$24K
  • Kuros Biosciences USA, Inc$7K
  • Johnson & Johnson$313
  • Si-bone, Inc.$271
  • Orthofix Medical, Inc.$48
  • plus $20 from 1 others

What the payments were for

  • Consulting fees$26,75045%
  • Speaking & faculty fees$15,66026%
  • Travel & lodging$9,94417%
  • Food & beverage$7,05612%
  • Education$5811%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)143$27,700
Stryker29$24,470
Kuros Biosciences USA, Inc10$7,169
Johnson & Johnson5$313
Si-bone, Inc.4$271
Orthofix Medical, Inc.2$48
Carlsmed, Inc.1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$59,991 in reported general payments places this provider in the 85th percentile of 533 orthopaedic surgery providers in Minnesota.

See all orthopaedic surgery providers in Minnesota →

Medicare billing

Part B allowed, 2024
$126,174
Medicare patients
190
Services billed
585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin117$1,105
Methocarbamol54$265
Methylprednisolone19$125
Prednisone31$86
Cyclobenzaprine Hcl17$86

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Minneapolis

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →